Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cell cycle reentry triggers hyperploidization and synaptic dysfunction followed by delayed cell death in differentiated cortical neurons

  • Barrio-Alonso, Estíbaliz
  • Hernández-Vivanco, Alicia
  • Walton, Chaska C.
  • Perea, Gertrudis
  • Frade López, José María
Cell cycle reentry followed by neuronal hyperploidy and synaptic failure are two early hallmarks of Alzheimer’s disease (AD), however their functional connection remains unexplored. To address this question, we induced cell cycle reentry in cultured cortical neurons by expressing SV40 large T antigen. Cell cycle reentry was followed by hyperploidy in ~70% of cortical neurons, and led to progressive axon initial segment loss and reduced density of dendritic PSD-95 puncta, which correlated with diminished spike generation and reduced spontaneous synaptic activity. This manipulation also resulted in delayed cell death, as previously observed in AD-affected hyperploid neurons. Membrane depolarization by high extracellular potassium maintained PSD-95 puncta density and partially rescued both spontaneous synaptic activity and cell death, while spike generation remained blocked. This suggests that AD-associated hyperploid neurons can be sustained in vivo if integrated in active neuronal circuits whilst promoting synaptic dysfunction. Thus, cell cycle reentry might contribute to cognitive impairment in early stages of AD and neuronal death susceptibility at late stages., This work was supported by Ministerio de Economía y Competitividad Grants SAF2015-68488-R (J.M.F.) and BFU2013-47265-R and BFU2016-75107-P (G.P.), and Intramural Grant 201620I017 (G.P.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer’s Disease Mice

  • Cuadrado-Tejedor, M.
  • Garcia-Barroso, Carolina
  • Sánchez-Arias, Juan A.
  • Rabal, Obdulia
  • Pérez-González, Marta
  • Mederos, Sara
  • Ugarte, Ana
  • Franco, Rafael
  • Segura, Víctor
  • Perea, Gertrudis
  • Oyarzabal, Julen
  • García-Osta, A.
The targeting of two independent but synergistic enzymatic activities, histone deacetylases (HDACs, class I and HDAC6) and phosphodiesterase 5 (PDE5), has recently been validated as a potentially novel therapeutic approach for Alzheimer’s disease (AD). Here we report the discovery of a new first-in-class small-molecule (CM-414) that acts as a dual inhibitor of PDE5 and HDACs. We have used this compound as a chemical probe to validate this systems therapeutics strategy, where an increase in the activation of cAMP/cGMP-responsive element-binding protein (CREB) induced by PDE5 inhibition, combined with moderate HDAC class I inhibition, leads to efficient histone acetylation. This molecule rescued the impaired long-term potentiation evident in hippocampal slices from APP/PS1 mice. Chronic treatment of Tg2576 mice with CM-414 diminished brain Aβ and tau phosphorylation (pTau) levels, increased the inactive form of GSK3β, reverted the decrease in dendritic spine density on hippocampal neurons, and reversed their cognitive deficits, at least in part by inducing the expression of genes related to synaptic transmission. Thus, CM-414 may serve as the starting point to discover balanced dual inhibitors with an optimal efficacy and safety profile for clinical testing on AD patients., Mar Cuadrado-Tejedor, Obdulia Rabal, Rafael Franco, Ana Garcia-Osta and Julen Oyarzabal are inventors of the reported patent WO 2014/131855 A1 claiming this chemical series. Applicant is Fundación para la Investigación Médica Aplicada (FIMA). The rest of authors declare no conflict of interest. This work was supported by grants from FIMA (Spain), the FIS project (11/02861 and 14/01244) to AG-O, a Torres Quevedo grant (from MINECO PTQ-12-05641) to AU, an Asociación de Amigos of University of Navarra grant to MP-G, and MINECO (Ramón y Cajal Program, RYC-2012-12014; and BFU2013-47265R) to GP.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

GABAergic-astrocyte signaling: A refinement of inhibitory brain networks

  • Mederos, Sara
  • Perea, Gertrudis
Interneurons play a critical role in precise control of network operation. Indeed, higher brain capabilities such as working memory, cognitive flexibility, attention, or social interaction rely on the action of GABAergic interneurons. Evidence from excitatory neurons and synapses has revealed astrocytes as integral elements of synaptic transmission. However, GABAergic interneurons can also engage astrocyte signaling; therefore, it is tempting to speculate about different scenarios where, based on particular interneuron cell type, GABAergic-astrocyte interplay would be involved in diverse outcomes of brain function. In this review, we will highlight current data supporting the existence of dynamic GABAergic-astrocyte communication and its impact on the inhibitory-regulated brain responses, bringing new perspectives on the ways astrocytes might contribute to efficient neuronal coding., The authors are grateful to Dr. C. Sánchez-Puelles and C. GonzálezArias for helpful comments. NB Revisions was used for manuscript editing. This work was supported by the PhD fellowship program (MINECO, BES-2014-067594) to SM; and MINECO grant (BFU2016- 75107-P), and and Cajal Blue Brain Project (Spanish partner of the Blue Brain Project initiative from EPFL) and the European Union Horizon 2020 research and innovation program under grant agreement No. 720270 (Human Brain Project, https://www.humanbrainproject.eu/) to GP.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Monitoring Interneuron-Astrocyte Signaling and Its Consequences on Synaptic Transmission

  • Mederos, Sara
  • Perea, Gertrudis
Whole-cell patch clamp allows the characterization of synaptic transmission in neurons. It is possible to manipulate astrocytic activity and record how these glial cells affect neuronal networks. Here we describe the methodology to monitor the endogenously activation of astrocytes by inhibitory synaptic activity. Afterward, such glial activation will let us study the consequences of interneuron-astrocyte signaling on excitatory neurotransmission at hippocampal synapses., This work was supported by PhD fellowship program (MINECO,BES-2014-067594) to S.M; and MINECO grants (BFU2016-75107-P) to G.P.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Melanopsin for precise optogenetic activation of astrocyte-neuron networks

  • Mederos, Sara
  • Hernández-Vivanco, Alicia
  • Ramírez-Franco, Jorge
  • Martín-Fernández, Mario
  • Navarrete, Marta
  • Yang, A.
  • Boyden, E.S.
  • Perea, Gertrudis
Optogenetics has been widely expanded to enhance or suppress neuronal activity and it has been recently applied to glial cells. Here, we have used a new approach based on selective expression of melanopsin, a G-protein-coupled photopigment, in astrocytes to trigger Ca2+ signaling. Using the genetically encoded Ca2+ indicator GCaMP6f and two-photon imaging, we show that melanopsin is both competent to stimulate robust IP3-dependent Ca2+ signals in astrocyte fine processes, and to evoke an ATP/Adenosine-dependent transient boost of hippocampal excitatory synaptic transmission. Additionally, under low-frequency light stimulation conditions, melanopsin-transfected astrocytes can trigger long-term synaptic changes. In vivo, melanopsin-astrocyte activation enhances episodic-like memory, suggesting melanopsin as an optical tool that could recapitulate the wide range of regulatory actions of astrocytes on neuronal networks in behaving animals. These results describe a novel approach using melanopsin as a precise trigger for astrocytes that mimics their endogenous G-protein signaling pathways, and present melanopsin as a valuable optical tool for neuron-glia studies., The authors thank Dr. J. Chen (UCSD, CA, USA) for providing IP3R2−/− mice; Dr. W. Buño, Dr. E. Martin and Dr. Araque for helpful comments; Dr. JA Esteban, C. Sánchez and M.A. Muñoz for helpful assistance with the two‐photon technical assistance; Dr. M. Valero for MATLAB advice. This work was supported by PhD fellowship program (MINECO, BES‐2014‐067594) to S.M; and MINECO grants (BFU2013‐47265R; Intramural 201620I017; BFU2016‐75107‐P) to G.P.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Neuron-astrocyte signaling is preserved in the aging brain

  • Gómez-Gonzalo, Marta
  • Martin-Fernandez, Mario
  • Martínez-Murillo, Ricardo
  • Mederos, Sara
  • Hernández-Vivanco, Alicia
  • Jamison, Stephanie
  • Fernandez, Ana P.
  • Serrano, Julia
  • Calero, Pilar
  • Futch, Hunter S.
  • Corpas, Rubén
  • Sanfeliu, Coral
  • Perea, Gertrudis
  • Araque, Alfonso
Astrocytes play crucial roles in brain homeostasis and are emerging as regulatory elements of neuronal and synaptic physiology by responding to neurotransmitters with Ca2+ elevations and releasing gliotransmitters that activate neuronal receptors. Aging involves neuronal and astrocytic alterations, being considered risk factor for neurodegenerative diseases. Most evidence of the astrocyte-neuron signaling is derived from studies with young animals; however, the features of astrocyte-neuron signaling in adult and aging brain remain largely unknown. We have investigated the existence and properties of astrocyte-neuron signaling in physiologically and pathologically aging mouse hippocampal and cortical slices at different lifetime points (0.5 to 20 month-old animals). We found that astrocytes preserved their ability to express spontaneous and neurotransmitter-dependent intracellular Ca2+ signals from juvenile to aging brains. Likewise, resting levels of gliotransmission, assessed by neuronal NMDAR activation by glutamate released from astrocytes, were largely preserved with similar properties in all tested age groups, but DHPG-induced gliotransmission was reduced in aged mice. In contrast, gliotransmission was enhanced in the APP/PS1 mouse model of Alzheimer's disease, indicating a dysregulation of astrocyte-neuron signaling in pathological conditions. Disruption of the astrocytic IP3 R2 mediated-signaling, which is required for neurotransmitter-induced astrocyte Ca2+ signals and gliotransmission, boosted the progression of amyloid plaque deposits and synaptic plasticity impairments in APP/PS1 mice at early stages of the disease. Therefore, astrocyte-neuron interaction is a fundamental signaling, largely conserved in the adult and aging brain of healthy animals, but it is altered in Alzheimer's disease, suggesting that dysfunctions of astrocyte Ca2+ physiology may contribute to this neurodegenerative disease. GLIA 2017 GLIA 2017;65:569-580., Grant sponsor: Research Grant; Grant number: R01NS097312-01; Grant sponsor: NIH-NINDS; Grant numbers: R01NS097312-01 We thank W. Buño for helpful comments; B. Pro, S. Fernández and M. Palancar for technical assistance; Dr. J. Chen (UCSD, USA) for providing IP3R2−/− mice. Work supported by MINECO: SAF2015-65586 to RM; SAF2012-39852-C02-02 to CS; BFU2013-47265-R, BFU2016-75107-P, and RYC-2012-12014 to GP; CSD2010-00045 to CS, GP and AA; Cajal Blue Brain, Human Frontier Science Program and R01NS097312-01 to A.A., Peer reviewed